Fredun Pharma
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
Get instant stock alerts
- Share Price
- Financials
- Revenue mix
- Shareholdings
- Peers
- Forensics
Share Price
Coming soon
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
Financials
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
| (In Cr.) |
|---|
| (In Cr.) | ||||
|---|---|---|---|---|
|
This data is currently unavailable for this company. |
| (In %) |
|---|
| (In Cr.) |
|---|
| Financial Year (In Cr.) |
|---|
Revenue mix
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Forensics
Recent events
-
News
-
Corporate Actions
May 25 (Reuters) - Fredun Pharmaceuticals Ltd FRED.BO:
FREDUN PHARMACEUTICALS MARCH-QUARTER CONSOL PROFIT 107.8 MILLION RUPEES
FREDUN PHARMACEUTICALS MARCH-QUARTER CONSOL NET INCOME FROM OPERATIONS 2.1 BILLION RUPEES
FREDUN PHARMACEUTICALS LTD - APPROVES BONUS ISSUE IN RATIO OF 2:1
Source text: ID:nBSE4lN1HZ
Further company coverage: FRED.BO
(([email protected];))
May 25 (Reuters) - Fredun Pharmaceuticals Ltd FRED.BO:
FREDUN PHARMACEUTICALS MARCH-QUARTER CONSOL PROFIT 107.8 MILLION RUPEES
FREDUN PHARMACEUTICALS MARCH-QUARTER CONSOL NET INCOME FROM OPERATIONS 2.1 BILLION RUPEES
FREDUN PHARMACEUTICALS LTD - APPROVES BONUS ISSUE IN RATIO OF 2:1
Source text: ID:nBSE4lN1HZ
Further company coverage: FRED.BO
(([email protected];))
April 29 (Reuters) - Fredun Pharmaceuticals Ltd FRED.BO:
FREDUN PHARMACEUTICALS - EXPANDS MANUFACTURING BASE WITH FIFTH FACILITY AT PALGHAR
FREDUN PHARMACEUTICALS - NEW FACILITY EXPECTED TO BE OPERATIONAL BY OCTOBER 2026
Source text: ID:nBSE46TGHd
Further company coverage: FRED.BO
(([email protected];))
April 29 (Reuters) - Fredun Pharmaceuticals Ltd FRED.BO:
FREDUN PHARMACEUTICALS - EXPANDS MANUFACTURING BASE WITH FIFTH FACILITY AT PALGHAR
FREDUN PHARMACEUTICALS - NEW FACILITY EXPECTED TO BE OPERATIONAL BY OCTOBER 2026
Source text: ID:nBSE46TGHd
Further company coverage: FRED.BO
(([email protected];))
Feb 9 (Reuters) - Fredun Pharmaceuticals Ltd FRED.BO:
FREDUN PHARMACEUTICALS DEC-QUARTER CONSOL PROFIT 104.8 MILLION RUPEES
FREDUN PHARMACEUTICALS DEC-QUARTER CONSOL INCOME FROM OPERATIONS 1.6 BILLION RUPEES
Source text: ID:nBSE52Blzf
Further company coverage: FRED.BO
(([email protected];))
Feb 9 (Reuters) - Fredun Pharmaceuticals Ltd FRED.BO:
FREDUN PHARMACEUTICALS DEC-QUARTER CONSOL PROFIT 104.8 MILLION RUPEES
FREDUN PHARMACEUTICALS DEC-QUARTER CONSOL INCOME FROM OPERATIONS 1.6 BILLION RUPEES
Source text: ID:nBSE52Blzf
Further company coverage: FRED.BO
(([email protected];))
Sept 25 (Reuters) - Fredun Pharmaceuticals Ltd FRED.BO:
FREDUN PHARMACEUTICALS LTD - TO ISSUE 652,360 EQUITY SHARES
FREDUN PHARMACEUTICALS LTD - TO ISSUE 573,600 CONVERTIBLE WARRANTS
FREDUN PHARMACEUTICALS - EQUITY SHARES TO BE ISSUED AT 1,250 RUPEES PER SHARE
FREDUN PHARMACEUTICALS LTD - SHARE WARRANTS TO BE ISSUED AT 1,250 RUPEES PER WARRANT
Source text: ID:nBSE48CVlF
Further company coverage: FRED.BO
(([email protected];;))
Sept 25 (Reuters) - Fredun Pharmaceuticals Ltd FRED.BO:
FREDUN PHARMACEUTICALS LTD - TO ISSUE 652,360 EQUITY SHARES
FREDUN PHARMACEUTICALS LTD - TO ISSUE 573,600 CONVERTIBLE WARRANTS
FREDUN PHARMACEUTICALS - EQUITY SHARES TO BE ISSUED AT 1,250 RUPEES PER SHARE
FREDUN PHARMACEUTICALS LTD - SHARE WARRANTS TO BE ISSUED AT 1,250 RUPEES PER WARRANT
Source text: ID:nBSE48CVlF
Further company coverage: FRED.BO
(([email protected];;))
July 10 (Reuters) - Fredun Pharmaceuticals Ltd FRED.BO:
FREDUN PHARMACEUTICALS LTD - COMPANY RECEIVES SEBI ADJUDICATION ORDER
FREDUN PHARMACEUTICALS LTD - NO MONETARY PENALTY IMPOSED BY SEBI
Source text: ID:nBSEbkxlxJ
Further company coverage: FRED.BO
(([email protected];;))
July 10 (Reuters) - Fredun Pharmaceuticals Ltd FRED.BO:
FREDUN PHARMACEUTICALS LTD - COMPANY RECEIVES SEBI ADJUDICATION ORDER
FREDUN PHARMACEUTICALS LTD - NO MONETARY PENALTY IMPOSED BY SEBI
Source text: ID:nBSEbkxlxJ
Further company coverage: FRED.BO
(([email protected];;))
** Shares of Fredun Pharmaceuticals FRED.BO climb 2.6% to 832 rupees
** The benchmark Nifty 50 .NSEI was down 0.5% on profit-taking in heavyweight financials
** Pharma firm forays into pet-care market on acquiring One Pet Stop, which has a costumer base of 4,000 pet owners
** Stock up ~13% YTD
(Reporting by Manvi Pant in Bengaluru)
(([email protected]; +918447554364;))
** Shares of Fredun Pharmaceuticals FRED.BO climb 2.6% to 832 rupees
** The benchmark Nifty 50 .NSEI was down 0.5% on profit-taking in heavyweight financials
** Pharma firm forays into pet-care market on acquiring One Pet Stop, which has a costumer base of 4,000 pet owners
** Stock up ~13% YTD
(Reporting by Manvi Pant in Bengaluru)
(([email protected]; +918447554364;))
April 9 (Reuters) - Fredun Pharmaceuticals Ltd FRED.BO:
AWARDED A SIGNIFICANT TENDER BY TAMIL NADU MEDICAL SERVICES CORP
TENDER VALUE BETWEEN 150 MILLION RUPEES AND 180 MILLION RUPEES
Source text: ID:nBSE77QdFx
Further company coverage: FRED.BO
(([email protected];;))
April 9 (Reuters) - Fredun Pharmaceuticals Ltd FRED.BO:
AWARDED A SIGNIFICANT TENDER BY TAMIL NADU MEDICAL SERVICES CORP
TENDER VALUE BETWEEN 150 MILLION RUPEES AND 180 MILLION RUPEES
Source text: ID:nBSE77QdFx
Further company coverage: FRED.BO
(([email protected];;))
March 18 (Reuters) - Fredun Pharmaceuticals Ltd FRED.BO:
FREDUN PHARMACEUTICALS LTD - PHARMA ANNOUNCES INTERNATIONAL EXPANSION OF FREOSSI DIVISION
FREDUN PHARMACEUTICALS LTD - PHARMA INTRODUCES 9 PREMIUM PETCARE PRODUCTS IN SRI LANKA
Source text: ID:nBSE533f4B
Further company coverage: FRED.BO
(([email protected];))
March 18 (Reuters) - Fredun Pharmaceuticals Ltd FRED.BO:
FREDUN PHARMACEUTICALS LTD - PHARMA ANNOUNCES INTERNATIONAL EXPANSION OF FREOSSI DIVISION
FREDUN PHARMACEUTICALS LTD - PHARMA INTRODUCES 9 PREMIUM PETCARE PRODUCTS IN SRI LANKA
Source text: ID:nBSE533f4B
Further company coverage: FRED.BO
(([email protected];))
Feb 3 (Reuters) - Fredun Pharmaceuticals Ltd FRED.BO:
FREDUN PHARMACEUTICALS - INSTALLS SECOND ITALIAN TUBE FILLING MACHINE
FREDUN PHARMACEUTICALS - INVESTMENT BOOSTS PRODUCTION CAPACITY BY 2.9 TIMES
Source text: ID:nBSE5BqF4w
Further company coverage: FRED.BO
(([email protected];))
Feb 3 (Reuters) - Fredun Pharmaceuticals Ltd FRED.BO:
FREDUN PHARMACEUTICALS - INSTALLS SECOND ITALIAN TUBE FILLING MACHINE
FREDUN PHARMACEUTICALS - INVESTMENT BOOSTS PRODUCTION CAPACITY BY 2.9 TIMES
Source text: ID:nBSE5BqF4w
Further company coverage: FRED.BO
(([email protected];))
Oct 3 (Reuters) - Fredun Pharmaceuticals Ltd FRED.BO:
APPROVED ISSUE OF FOREIGN CURRENCY CONVERTIBLE BONDS WORTH USD 10 MILLION
MAY ISSUE FURTHER FOREIGN CURRENCY CONVERTIBLE BONDS WORTH USD 2 MILLION
Source text for Eikon: ID:nBSE7dkdxL
Further company coverage: FRED.BO
(([email protected];;))
Oct 3 (Reuters) - Fredun Pharmaceuticals Ltd FRED.BO:
APPROVED ISSUE OF FOREIGN CURRENCY CONVERTIBLE BONDS WORTH USD 10 MILLION
MAY ISSUE FURTHER FOREIGN CURRENCY CONVERTIBLE BONDS WORTH USD 2 MILLION
Source text for Eikon: ID:nBSE7dkdxL
Further company coverage: FRED.BO
(([email protected];;))
Sept 26 (Reuters) - Fredun Pharmaceuticals Ltd FRED.BO:
FREDUN PHARMACEUTICALS - TO CONSIDER ISSUE OF FOREIGN CURRENCY CONVERTIBLE BONDS
Source text for Eikon: ID:nBSEb7K6YQ
Further company coverage: FRED.BO
(([email protected];))
Sept 26 (Reuters) - Fredun Pharmaceuticals Ltd FRED.BO:
FREDUN PHARMACEUTICALS - TO CONSIDER ISSUE OF FOREIGN CURRENCY CONVERTIBLE BONDS
Source text for Eikon: ID:nBSEb7K6YQ
Further company coverage: FRED.BO
(([email protected];))
Feb 12 (Reuters) - Fredun Pharmaceuticals Ltd FRED.BO:
SECURES ORDERS FROM SEA COUNTRIES
ORDERS WORTH 280 MILLION RUPEES
EXPANDS PRODUCT DEVELOPMENT IN VETERINARY CARE, ADVANCES ORTHOPAEDIC APPLICATIONS
Source text for Eikon: ID:nBSEDCn96
Further company coverage: FRED.BO
(([email protected];))
Feb 12 (Reuters) - Fredun Pharmaceuticals Ltd FRED.BO:
SECURES ORDERS FROM SEA COUNTRIES
ORDERS WORTH 280 MILLION RUPEES
EXPANDS PRODUCT DEVELOPMENT IN VETERINARY CARE, ADVANCES ORTHOPAEDIC APPLICATIONS
Source text for Eikon: ID:nBSEDCn96
Further company coverage: FRED.BO
(([email protected];))
Dec 21 (Reuters) - Fredun Pharmaceuticals Ltd FRED.BO:
DAULAT NARIMAN MEDHORA REAPPOINTED AS WHOLE TIME DIRECTOR DESIGNATED AS JOINT MANAGING DIRECTOR
Further company coverage: FRED.BO
(([email protected];))
Dec 21 (Reuters) - Fredun Pharmaceuticals Ltd FRED.BO:
DAULAT NARIMAN MEDHORA REAPPOINTED AS WHOLE TIME DIRECTOR DESIGNATED AS JOINT MANAGING DIRECTOR
Further company coverage: FRED.BO
(([email protected];))
Dec 8 (Reuters) - Fredun Pharmaceuticals Ltd FRED.BO:
TO CONSIDER A PROPOSAL FOR FUND RAISING
TO CONSIDER A PROPOSAL FOR FUND RAISING WORTH UPTO 1.2 BILLION RUPEES
Source text for Eikon: ID:nBSE8bp1rl
Further company coverage: FRED.BO
(([email protected];))
Dec 8 (Reuters) - Fredun Pharmaceuticals Ltd FRED.BO:
TO CONSIDER A PROPOSAL FOR FUND RAISING
TO CONSIDER A PROPOSAL FOR FUND RAISING WORTH UPTO 1.2 BILLION RUPEES
Source text for Eikon: ID:nBSE8bp1rl
Further company coverage: FRED.BO
(([email protected];))
Nov 8 (Reuters) - Fredun Pharmaceuticals Ltd FRED.BO:
RE-APPOINTS FREDUN MEDHORA AS MD
Source text for Eikon: ID:nBSE5KFFg9
Further company coverage: FRED.BO
(([email protected];))
Nov 8 (Reuters) - Fredun Pharmaceuticals Ltd FRED.BO:
RE-APPOINTS FREDUN MEDHORA AS MD
Source text for Eikon: ID:nBSE5KFFg9
Further company coverage: FRED.BO
(([email protected];))
July 19 (Reuters) - Fredun Pharmaceuticals Ltd FRED.BO:
JUNE-QUARTER NET PROFIT 24 MILLION RUPEES VERSUS PROFIT 9.4 MILLION RUPEES
JUNE-QUARTER INCOME FROM OPERATIONS 612.3 MILLION RUPEES VERSUS 481.3 MILLION RUPEES
Source text for Eikon: ID:nBSE1BDGBw
Further company coverage: FRED.BO
(([email protected];))
July 19 (Reuters) - Fredun Pharmaceuticals Ltd FRED.BO:
JUNE-QUARTER NET PROFIT 24 MILLION RUPEES VERSUS PROFIT 9.4 MILLION RUPEES
JUNE-QUARTER INCOME FROM OPERATIONS 612.3 MILLION RUPEES VERSUS 481.3 MILLION RUPEES
Source text for Eikon: ID:nBSE1BDGBw
Further company coverage: FRED.BO
(([email protected];))
May 25 (Reuters) - Fredun Pharmaceuticals Ltd FRED.BO:
MARCH-QUARTER PROFIT 38.9 MILLION RUPEES VERSUS 23 MILLION RUPEES YEAR AGO
MARCH-QUARTER TOTAL INCOME FROM OPERATIONS 798 MILLION RUPEES VERSUS 718.5 MILLION RUPEES YEAR AGO
Source text for Eikon: ID:nBSEb7lWKb
Further company coverage: FRED.BO
(([email protected];))
May 25 (Reuters) - Fredun Pharmaceuticals Ltd FRED.BO:
MARCH-QUARTER PROFIT 38.9 MILLION RUPEES VERSUS 23 MILLION RUPEES YEAR AGO
MARCH-QUARTER TOTAL INCOME FROM OPERATIONS 798 MILLION RUPEES VERSUS 718.5 MILLION RUPEES YEAR AGO
Source text for Eikon: ID:nBSEb7lWKb
Further company coverage: FRED.BO
(([email protected];))
More Micro Cap Ideas
See similar 'Micro' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
- Business
- Financials
- Share Price
- Shareholdings
What does Fredun Pharma do?
Fredun Pharmaceuticals Limited is a trusted manufacturer of pharmaceutical products, dietary supplements, nutraceuticals, and healthcare products in Africa, Southeast Asia, CIS countries, and Latin America, aiming to be a holistic healthcare provider.
Who are the competitors of Fredun Pharma?
Fredun Pharma major competitors are Jagsonpal Pharma, Syncom Formulations, Lincoln Pharma, Wanbury, Ind-Swift Labs., Sakar Healthcare, Bharat Parenterals. Market Cap of Fredun Pharma is ₹1,558 Crs. While the median market cap of its peers are ₹1,293 Crs.
Is Fredun Pharma financially stable compared to its competitors?
Fredun Pharma seems to be less financially stable compared to its competitors. Altman Z score of Fredun Pharma is 4.9 and is ranked 6 out of its 8 competitors.
Does Fredun Pharma pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Fredun Pharma latest dividend payout ratio is 1.17% and 3yr average dividend payout ratio is 1.65%
How has Fredun Pharma allocated its funds?
Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Cash & Short Term Investments, Short Term Loans & Advances
How strong is Fredun Pharma balance sheet?
Balance sheet of Fredun Pharma is strong. But short term working capital might become an issue for this company.
Is the profitablity of Fredun Pharma improving?
Yes, profit is increasing. The profit of Fredun Pharma is ₹32.62 Crs for Mar 2026, ₹19.74 Crs for Mar 2025 and ₹15.62 Crs for Mar 2024
Is the debt of Fredun Pharma increasing or decreasing?
The net debt of Fredun Pharma is decreasing. Latest net debt of Fredun Pharma is ₹92.62 Crs as of Mar-26. This is less than Mar-25 when it was ₹157 Crs.
Is Fredun Pharma stock expensive?
Yes, Fredun Pharma is expensive. Latest PE of Fredun Pharma is 47.77, while 3 year average PE is 40.28. Also latest EV/EBITDA of Fredun Pharma is 18.15 while 3yr average is 17.41.
Has the share price of Fredun Pharma grown faster than its competition?
Fredun Pharma has given better returns compared to its competitors. Fredun Pharma has grown at ~31.17% over the last 8yrs while peers have grown at a median rate of 26.73%
Is the promoter bullish about Fredun Pharma?
Promoters seem to be bullish about the company. Latest quarter promoter holding is 44.57% and last quarter promoter holding is 44.17%.
Are mutual funds buying/selling Fredun Pharma?
There is Insufficient data to gauge this.